substance p has been researched along with Sleep Apnea Syndromes in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (40.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kumar, GK; Lee, MS; Prabhakar, NR; Raghuraman, G; Sharma, SD | 1 |
| Veasey, S | 1 |
| Coleman, CG; Lessard, A; Pickel, VM | 1 |
| Feldman, JL; Janczewski, WA; McKay, LC | 1 |
| Eichling, PS; Sahni, J | 1 |
| Feldman, JL; McKay, LC | 1 |
| Friberg, D; Gazelius, B; Hökfelt, T; Nordlander, B | 1 |
| Bisette, G; Gislason, T; Hedner, J; Nemeroff, CB; Terenius, L | 1 |
| Grunstein, RR; Ho, KY; Parker, S; Scheibner, T; Sullivan, CE | 1 |
| Glaser, S; Knöfel, B; Oehme, P; Rathsack, R; Scheidt, B; Scholle, S; Zwacka, G | 1 |
1 review(s) available for substance p and Sleep Apnea Syndromes
| Article | Year |
|---|---|
Menopause related sleep disorders.
Topics: Depression; Estrogen Replacement Therapy; Estrogens; Female; Fibromyalgia; Humans; Hydrocortisone; Melatonin; Menopause; Phytotherapy; Polysomnography; Progesterone; Serotonin; Sleep Apnea Syndromes; Sleep Initiation and Maintenance Disorders; Sleep Stages; Substance P; Testosterone | 2005 |
9 other study(ies) available for substance p and Sleep Apnea Syndromes
| Article | Year |
|---|---|
Intermittent hypoxia activates peptidylglycine alpha-amidating monooxygenase in rat brain stem via reactive oxygen species-mediated proteolytic processing.
Topics: Amidine-Lyases; Animals; Antioxidants; Brain Stem; Disease Models, Animal; Enzyme Activation; Hypoxia; Kinetics; Male; Metalloporphyrins; Mixed Function Oxygenases; Multienzyme Complexes; Neuropeptide Y; Peptide Hydrolases; Protein Processing, Post-Translational; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; Sleep Apnea Syndromes; Substance P | 2009 |
Peptide amidation: a push me, don't pull you for the morbidities in sleep apnea.
Topics: Amidine-Lyases; Animals; Brain Stem; Enzyme Activation; Humans; Hypoxia; Mixed Function Oxygenases; Multienzyme Complexes; Neuropeptide Y; Protein Processing, Post-Translational; Reactive Oxygen Species; Signal Transduction; Sleep Apnea Syndromes; Substance P | 2009 |
Chronic intermittent hypoxia reduces neurokinin-1 (NK(1)) receptor density in small dendrites of non-catecholaminergic neurons in mouse nucleus tractus solitarius.
Topics: Animals; Catecholamines; Chronic Disease; Dendrites; Fluorescent Antibody Technique; Hypoxia, Brain; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Microscopy, Immunoelectron; Neuronal Plasticity; Neurons; Receptors, Neurokinin-1; Reflex; Respiratory Mechanics; Sleep Apnea Syndromes; Solitary Nucleus; Substance P; Sympathetic Nervous System; Trigeminal Nucleus, Spinal; Tyrosine 3-Monooxygenase | 2010 |
Sleep-disordered breathing after targeted ablation of preBötzinger complex neurons.
Topics: Animals; Cell Death; Disease Models, Animal; Electroencephalography; Electromyography; Immunohistochemistry; Immunotoxins; Neurons; Polysomnography; Rats; Receptors, Neurokinin-1; Respiratory Center; Ribosome Inactivating Proteins, Type 1; Saporins; Sleep Apnea Syndromes; Sleep, REM; Substance P; Time Factors; Wakefulness | 2005 |
Unilateral ablation of pre-Botzinger complex disrupts breathing during sleep but not wakefulness.
Topics: Animals; Electroencephalography; Electromyography; Injections; Male; Medulla Oblongata; Neurons; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Respiration; Ribosome Inactivating Proteins, Type 1; Saporins; Sleep Apnea Syndromes; Sleep, REM; Substance P; Wakefulness | 2008 |
Abnormal afferent nerve endings in the soft palatal mucosa of sleep apnoics and habitual snorers.
Topics: Adult; Aged; Biopsy; Calcitonin Gene-Related Peptide; Humans; Immunohistochemistry; Male; Middle Aged; Mouth Mucosa; Nasal Mucosa; Nerve Tissue Proteins; Neurons, Afferent; Palate; Sleep Apnea Syndromes; Snoring; Substance P; Thiolester Hydrolases; Ubiquitin Thiolesterase | 1997 |
Substance P, thyrotropin-releasing hormone, and monoamine metabolites in cerebrospinal fluid in sleep apnea patients.
Topics: Adult; Biogenic Monoamines; Chromatography, High Pressure Liquid; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Sleep Apnea Syndromes; Substance P; Thyrotropin-Releasing Hormone | 1992 |
Ventilatory control in sleep apnea: a search for brain neurochemical defects.
Topics: Acromegaly; Airway Resistance; Brain; Brain Mapping; Brain Stem; Carbon Dioxide; Carotid Body; Chemoreceptor Cells; Humans; Hypothalamus; Medulla Oblongata; Neural Inhibition; Neural Pathways; Neurotransmitter Agents; Positive-Pressure Respiration; Sleep Apnea Syndromes; Somatostatin; Substance P | 1990 |
Substance P, mean apnoea duration and the sudden infant death syndrome (SIDS).
Topics: Humans; Infant; Infant, Newborn; Infant, Premature; Respiratory System; Risk; Sleep Apnea Syndromes; Substance P; Sudden Infant Death; Time Factors | 1990 |